Systemic and Tumor Th1 and Th2 Inflammatory Profile and Macrophages in Lung Cancer: Influence of Underlying Chronic Respiratory Disease
Authors:
- 1 February 2017
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 12 (2) , 235-248
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- The Tissue Microlocalisation and Cellular Expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 Is Correlated to Clinical Outcome in NSCLCPLOS ONE, 2011
- The role of inflammation in the pathogenesis of lung cancerExpert Opinion on Therapeutic Targets, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detectionBest Practice & Research Clinical Gastroenterology, 2010
- Inflammation and esophageal carcinogenesisCurrent Opinion in Pharmacology, 2009
- Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survivalEuropean Respiratory Journal, 2008
- Inflammation, atrophy, and gastric cancerJournal of Clinical Investigation, 2007
- Macrophage and Mast-Cell Invasion of Tumor Cell Islets Confers a Marked Survival Advantage in Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2005
- Cigarette Smoke‐Induced Oxidative Stress and TGF‐β1Increase p21waf1/cip1Expression in Alveolar Epithelial CellsAnnals of the New York Academy of Sciences, 2002